News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Elutia
NEWS
JOBS
NEWS
FDA
Excessive Impurities Cause Recall of Pfizer’s Anti-Smoking Drug
Pfizer has voluntarily recalled two lots of Chantix 0.5 mg tablets, two lots of Chantix 1 mg tablets, and eight lots of a Chantix kit consisting of 0.5mg/1 mg tablets.
July 20, 2021
·
2 min read
·
Brandon May
Business
Aziyo Biologics Banks Some Cash And Former Osiris Exec As Its New CEO
June 15, 2017
·
1 min read
IN THE PRESS
BioCapital
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance
December 18, 2023
·
6 min read
BioCapital
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
November 9, 2023
·
5 min read
Business
Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
November 6, 2023
·
1 min read
BioCapital
Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference
September 20, 2023
·
1 min read
BioCapital
Elutia Announces Private Placement for Proceeds Up to $26 Million
September 19, 2023
·
7 min read
BioCapital
Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
September 18, 2023
·
6 min read
BioCapital
Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 8, 2023
·
1 min read
Business
Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices
September 6, 2023
·
5 min read
BioCapital
Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures
August 30, 2023
·
6 min read
Business
Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company
August 14, 2023
·
11 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details